James Shannon

Supervisory Board
Molecular Biology
ProQR
Netherlands

Business Expert Molecular Biology
Biography

 James Shannon, MD has served on our Supervisory Board since June 2016. James has had an extensive career in drug development and pharma. From 2012 until his retirement in 2015, James was Chief Medical Officer at GlaxoSmithKline. Prior to that he was Global Head of Pharma Development at Novartis and Senior Vice-President, Clinical Development at Sterling Winthrop Pharmaceuticals. He held board positions at companies including Biotie, Circassia, Crucell, Endocyte, MannKind and Cerimon Pharmaceuticals. He received his undergraduate and postgraduate degrees at Queen's University of Belfast and is a Member of the Royal College of Physicians (UK).  

Research Intrest

Drug Development, Molecular Genetics